Arrowhead Pharmaceuticals, Inc. (ARWR) Financials

ARWR Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 2.1 billion 1.6 billion
March 31, 2026 2.3 billion 1.7 billion
Dec. 31, 2025 1.6 billion 1.0 billion
Sept. 30, 2025 1.4 billion 881.9 million

ARWR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -181.3 million 14.7 million
March 31, 2026 81.9 million 16.8 million
Dec. 31, 2025 11.3 million 19.4 million
Sept. 30, 2025 13.0 million 19.1 million

ARWR Net Income

No data available :(

ARWR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 1.6 billion 824.1 million 119.6 million
March 31, 2026 1.8 billion 1.2 billion 100.1 million
Dec. 31, 2025 916.6 million 163.1 million 109.7 million
Sept. 30, 2025 919.4 million 214.9 million 111.4 million

ARWR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 143.4 million
March 31, 2026 142.4 million
Dec. 31, 2025 140.7 million
Sept. 30, 2025 135.7 million

ARWR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 3.9 million 198.2 million 47.1 million -
March 31, 2026 2.6 million 173.3 million 41.2 million -
Dec. 31, 2025 2.1 million 177.2 million 45.5 million -
Sept. 30, 2025 7.5 million 174.7 million 37.2 million -

ARWR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 75.3 million -
March 31, 2026 73.7 million 6.4 million
Dec. 31, 2025 264.0 million 6.4 million
Sept. 30, 2025 256.5 million 6.4 million

ARWR

Price: $86.64

52 week price:
15.01
95.49

Earnings Per Share: -2.28 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 594870

Ebitda: -12.7 million

Market Capitalization: 12.5 billion

Links: